Koroner arter baypass cerrahisinde statinin antikardiyolipin antikor seviyelerine etkisi
Open Access
- 31 August 2023
- journal article
- research article
- Published by Ege Tip Bilimleri Dergisi in Ege Tıp Bilimleri Dergisi
- Vol. 6 (2) , 42-47
Abstract
Objectives: The aim of this research is to study the link between lipid lowering mechanism and other beneficial biological effects of statin in patients of coronary bypass surgery by revealing the relation of preoperative statin on pre- , peri- and postoperative cardiolipin IgG and IgM antibody levels. The case in open cardiac surgery was not keeping the heart beating only but preventing or minimizing the myocardial injury. For this reason, a new method for preservation of blood elements and myocardium must be uncovered. Material and Methods: Thirty patients with coronary ischemic disease whose scheduled to undergo elective coronary artery bypass graft surgery and fitting the criteria for our research were divided in to two groups, those on standard lipid lowering therapy using atorvastatin ( 40 mg/day ) for at least 7 days prior to surgery (group A) and second group those without regular lipid lowering therapy preoperatively (B). All the parameters were documented and recorded, including demographic, hemodynamic, laboratory and surgical technique with outcome. Results: The recorded parameters and values were analyzed using the following tests in computer program: Kolmogorov- Smirnov test, student t test, paired t test and Chi- square test. All results were scheduled in 6 tables for simple and better evaluation. Conclusion: The findings support the beneficial effects of statin in the perioperative and early postoperative (first 24 hours) in open cardiac surgery.Keywords
This publication has 24 references indexed in Scilit:
- Perioperative ??-Blockers for Preventing Surgery-Related Mortality and Morbidity: A Systematic Review and Meta-AnalysisAnesthesia & Analgesia, 2007
- Role of statin therapy in the coronary bypass patientThe Annals of Thoracic Surgery, 2004
- Beneficial Cardiovascular Pleiotropic Effects of StatinsCirculation, 2004
- Statins Are Associated With a Reduced Incidence of Perioperative Mortality in Patients Undergoing Major Noncardiac Vascular SurgeryCirculation, 2003
- Expanding indications of statins; implications of the Heart Protection StudyExpert Opinion on Investigational Drugs, 2003
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialThe Lancet, 2002
- PROAPOPTOTIC EFFECT OF ATORVASTATIN ON STIMULATED RABBIT SMOOTH MUSCLE CELLSPharmacological Research, 1997
- Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein.Journal of Clinical Investigation, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- HMG CoA reductase inhibitorsCurrent Opinion in Lipidology, 1992